Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1989 Jul 1;170(1):87-104.
doi: 10.1084/jem.170.1.87.

Tolerance in transgenic mice expressing class II major histocompatibility complex on pancreatic acinar cells

Affiliations

Tolerance in transgenic mice expressing class II major histocompatibility complex on pancreatic acinar cells

D Lo et al. J Exp Med. .

Abstract

To study the nature of tolerance to antigens not expressed by cells of the lymphoid system, expression of class II MHC I-E was targeted to the acinar cells of the exocrine pancreas in transgenic mice (elastase [EL]-I-E). Despite the absence of detectable I-E in the thymus of EL-I-E transgenic mice, both thymocytes and peripheral T lymphocytes were tolerant to I-E, and the pancreas was free of autoimmune infiltrates. Nontolerant T cells adoptively transferred into irradiated or T-depleted transgenic mice rapidly destroy the I-E+ components of the pancreas; however, adoptive transfer of nontolerant T lymphocytes into nonirradiated transgenic mice do not. These results suggest that tolerance in transgenic mice is maintained by some peripheral tolerance mechanism. However, further studies indicate that tolerance in transgenic mice is not maintained by specific Ts cells. For example, cell mixing experiments both in vitro and in vivo fail to reveal dominant unresponsiveness. Furthermore, nontolerant T cells injected into otherwise unmanipulated EL-I-E mice can be primed in situ (by injections of I-E+ spleen cells) to destroy the I-E+ acinar cells.

PubMed Disclaimer

References

    1. J Exp Med. 1978 Jul 1;148(1):103-14 - PubMed
    1. J Immunol. 1989 Mar 15;142(6):2081-8 - PubMed
    1. Immunogenetics. 1981;14(1-2):15-27 - PubMed
    1. Nature. 1982 Nov 18;300(5889):262-4 - PubMed
    1. J Exp Med. 1982 Dec 1;156(6):1577-86 - PubMed

Publication types

Substances